Expression of dentin matrix protein 1 in tumors causing oncogenic osteomalacia.
Oncogenic osteomalacia, which is characterized by renal phosphate wasting, low serum 1, 25-dihydroxyvitamin D, and osteomalacia, is caused by mesenchymal neoplasms that are termed phosphaturic mesenchymal tumors (PMTs). As PMTs are usually small and lack specific histological features, the pathological identification of PMTs is difficult. Dentin matrix protein 1 (DMP1) is an acidic phosphoprotein expressed in mineralized tissues including bone, tooth, and hypertrophic cartilage. Increased expression of DMP1 gene in PMTs has been reported by using differential cDNA screening. In the present study, DMP1 expression in PMTs and other soft tissue tumors was analyzed immunohistochemically to verify its utility in the differential diagnosis of PMTs. Anti-DMP1 polyclonal antibody was raised against the C-terminal sequence of DMP1. Three cases with PMTs and 11 other soft tissue tumors (two malignant hemangiopericytomas, three solitary fibrous tumors, three synovial sarcomas, and three malignant peripheral nerve sheath tumors) were analyzed for DMP1 expression. DMP1 expression was observed in all of the three cases with PMTs, but never found in other soft tissue tumors examined. DMP1 was detected in the extracellular matrix with myxomatous features or around capillary vessels, and in dystrophic calcified sites. Paranuclear DMP1 staining in the tumor cells was also observed. These findings indicate that DMP1 immunohistochemistry is a useful tool for identifying PMTs.
Department of Oral Pathology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan. toyosawa@dent.osaka-u.ac.jp
Satoru
S
Toyosawa
Yasuhiko
Y
Tomita
Mitsunobu
M
Kishino
Jun
J
Hashimoto
Takafumi
T
Ueda
Takahiro
T
Tsujimura
Katsuyuki
K
Aozasa
Naokuni
N
Ijuhin
Toshihisa
T
Komori
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000595:Amino Acid Sequence; D000918:Antibody Specificity; D018952:Antigens, CD34 / Q000032:analysis; D016326:Extracellular Matrix Proteins; D026122:Factor XIIIa / Q000032:analysis; D005260:Female; D006393:Hemangiopericytoma / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008637:Mesenchymoma / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D008875:Middle Aged; D008969:Molecular Sequence Data; D010018:Osteomalacia / Q000209:etiology*; D014176:Protein Biosynthesis; D011506:Proteins / Q000235:genetics / Q000276:immunology; D017386:Sequence Homology, Amino Acid; D014746:Vimentin / Q000032:analysis
D018952:Antigens, CD34; D016326:Extracellular Matrix Proteins; D011506:Proteins; D014746:Vimentin; D026122:Factor XIIIa